Ignite Creation Date:
2024-05-05 @ 5:18 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00427882
Status:
COMPLETED
Last Update Posted:
2007-11-29
First Post:
2007-01-25
Brief Title:
Male Sexual Health Questionnaire MSHQ - Sexual Function Study
Sponsor:
Handok Inc
Organization:
Handok Inc
Study Overview
Official Title:
An Open Non-Comparative Multicenter Study on the Sexual Function Improvement Following Treatment With Alfuzosin in Patients With Benign Prostate Hyperplasia
Status:
COMPLETED
Status Verified Date:
2007-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Primary
To assess improvement in ejaculation from baseline to the end of treatment Week 12 or premature withdrawal with Alfuzosin 10mg OD using MSHQ score
Secondary
To evaluate sexual function improvement
To evaluate LUTS Lower Uninary Tract Symptoms improvement
To evaluate the association between LUTS severity and sexual function
To assess the safety and the tolerability of Alfuzosin 10mg OD
To assess improvement in ejaculation from baseline to the end of treatment Week 12 or premature withdrawal with Alfuzosin 10mg OD using MSHQ score
Secondary
To evaluate sexual function improvement
To evaluate LUTS Lower Uninary Tract Symptoms improvement
To evaluate the association between LUTS severity and sexual function
To assess the safety and the tolerability of Alfuzosin 10mg OD
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None